# CORRESP — FibroBiologics, Inc.  (FBLG)  (CIK 0001958777)

> <strong>FibroBiologics, Inc.  (FBLG)  (CIK 0001958777) → SEC staff</strong> · filed 2026-03-27 · ticker FBLG · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-013347
- **Form:** CORRESP
- **Filer:** FibroBiologics, Inc.  (FBLG)  (CIK 0001958777)
- **CIK:** 0001958777
- **Ticker:** FBLG
- **Filed:** 2026-03-27
- **SIC industry:** 2834
- **HQ:** Houston, TX

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1958777/000149315226013347/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1958777&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for FibroBiologics, Inc.  (FBLG)  (CIK 0001958777)

- CORRESP — 2026-03-27 — /comment-letter/0001493152-26-013346
- UPLOAD — 2026-03-24 — /comment-letter/0000000000-26-002965

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, FibroBiologics, Inc.  (FBLG)  (CIK 0001958777) (CIK 0001958777), filed 2026-03-27, accession 0001493152-26-013347. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001493152-26-013347.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*